Overview

Electroconvulsive Therapy in Clozapine Refractory Schizophrenia

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate electroconvulsive therapy (ECT) in patients who have not responded adequately to clozapine.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Northwell Health
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Clozapine